Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice

Nature Microbiology

Volumn 3, Issue 2, 2018, Pages 234-242

  Schulfer, Anjelique F ^a,b   Battaglia, Thomas ^b   Alvarez, Yelina ^b   Bijnens, Luc ^c   Ruiz, Victoria E ^b,d   Ho, Melody ^b   Robinson, Serina ^e   Ward, Tonya ^e   Cox, Laura M ^b,f   Rogers, Arlin B ^g   Knights, Dan ^h   Sartor, R Balfour ⁱ   Blaser, Martin J ^a,b,j  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d Janssen Pharmaceutical Companies of JandJ ^*  (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g TUFTS UNIVERSITY   (United States)

^h University of Minnesota   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALGRANULIN; INTERLEUKIN 10; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ANTIINFECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSMISSION; BODY COMPOSITION; CECUM; COLITIS; COLON TISSUE; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HISTOPATHOLOGY; INOCULATION; INTESTINE FLORA; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROGENY; SMALL INTESTINE; WHOLE GENOME SEQUENCING; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLON; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG EFFECT; DYSBIOSIS; FECES; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; LIPID DIET; METAGENOME; MICROBIOLOGY; PATHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; COLITIS; COLON; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; METAGENOME; MICE; MICE, INBRED C57BL; PHENOTYPE; PREGNANCY;

EID: 85035087059     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/s41564-017-0075-5     Document Type: Article

References (63)

1. Jernberg, C., Löfmark, S., Edlund, C. & Jansson, J. K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1, 56-66 (2007).
2. Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721 (2014).
3. Azad, M. B., Bridgman, S. L., Becker, A. B. & Kozyrskyj, A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obesity 38, 1290-1298 (2014).
4. Arrieta, M.-C. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 7, 307ra152 (2015).
5. Hviid, A., Svanstrom, H. & Frisch, M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 60, 49-54 (2011).
6. Shaw, S. Y., Blanchard, J. F. & Bernstein, C. N. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am. J. Gastroenterol. 106, 2133-2142 (2011).
7. Ng, S. C. et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 62, 630-649 (2013).
8. Kronman, M. P., Zaoutis, T. E., Haynes, K., Feng, R. & Coffin, S. E. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130, e794-e803 (2012).
9. Van Boeckel, T. P. et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14, 742-750 (2014).
10. Hicks, L. A. et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin. Infect. Dis. 60, 1308-1316 (2015).
11. Stokholm, J. et al. Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS ONE 8, e82932 (2013).
12. Andrade, S. E. et al. Prescription drug use in pregnancy. Am. J. Obstet. Gynecol. 191, 398-407 (2004).
13. Lacroix, I. et al. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur. J. Clin. Pharmacol. 65, 839-846 (2009).
14. Petersen, I., Gilbert, R., Evans, S., Ridolfi, A. & Nazareth, I. Oral antibiotic prescribing during pregnancy in primary care: UK population-based study. J. Antimicrob. Chemoth. 65, 2238-2246 (2010).
15. Metsälä, J. et al. Mother's and offspring's use of antibiotics and infant allergy to cow's milk. Epidemiology 24, 303-309 (2013).
16. Moeller, A. H. et al. Cospeciation of gut microbiota. Science 353, 380-382 (2016).
17. Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789-799 (2014).
18. Sonnenburg, E. D. et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529, 212-215 (2016).
19. Kühn, R., Löhler, J., Rennick, D., Rajewsky, K. & Müller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
20. Sellon, R. K. et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231 (1998).
21. Krause, P. et al. IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis. Nat. Commun. 6, 7055 (2015).
22. Sartor, R. B. & Wu, G. D. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 152, 327-339 (2017).
23. Jones-Hall, Y. L. & Grisham, M. B. Immunopathological characterization of selected mouse models of inflammatory bowel disease: comparison to human disease. Pathophysiology 21, 267-288 (2014).
24. Manichanh, C. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211 (2006).
25. Livanos, A. E. et al. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat. Microbiol. 1, 16140 (2016).
26. Pedersen, H. K. et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535, 376-381 (2016).
27. Oreši?, M. et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J. Exp. Med. 205, 2975-2984 (2008).
28. Nagata, C. et al. Branched-chain amino acid intake and the risk of diabetes in a Japanese community: the Takayama study. Am. J. Epidemiol. 178, 1226-1232 (2013).
29. Lynch, C. J. & Adams, S. H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10, 723-736 (2014).
30. Attene-Ramos, M. S. et al. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ. Mol. Mutagen. 51, 304-314 (2010).
31. Van Passel, M. W. J. et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 6, e16876 (2011).
32. Cohen, S. L., Moore, A. M. & Ward, W. E. Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation. Inflamm. Bowel Dis. 10, 557-563 (2004).
33. Mahana, D. et al. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. Genome Med. 8, 48 (2016).
34. Spencer, D. M., Veldman, G. M., Banerjee, S., Willis, J. & Levine, A. D. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 122, 94-105 (2002).
35. Berg, D. J. et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ Th1-like responses. J. Clin. Invest. 98, 1010-1020 (1996).
36. Lehmann, F. S., Burri, E. & Beglinger, C. The role and utility of faecal markers in inflammatory bowel disease. Ther. Adv. Gastroenter. 8, 23-36 (2015).
37. Chassaing, B. et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS ONE 7, e44328 (2012).
38. Hansen, J. J., Holt, L. & Sartor, R. B. Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflamm. Bowel Dis. 15, 890-899 (2009).
39. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
40. Miyoshi, J. et al. Peripartum antibiotics promote gut dysbiosis, loss of immune tolerance, and inflammatory bowel disease in genetically prone offspring. Cell Rep. 20, 491-504 (2017).
41. Metsälä, J. et al. Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood. Clin. Exp. Allergy 45, 137-145 (2015).
42. Gensollen, T., Iyer, S. S., Kasper, D. L. & Blumberg, R. S. How colonization by microbiota in early life shapes the immune system. Science 352, 539-544 (2016).
43. Gomez de Aguero, M. et al. The maternal microbiota drives early postnatal innate immune development. Science 351, 1296-1302 (2016).
44. Bokulich, N. A. et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci. Transl. Med. 8, 343ra82 (2016).
45. Asnicar, F. et al. Studying vertical microbiome transmission from mothers to infants by strain-level metagenomic profiling. mSystems 2, e00164-16 (2017).
46. Nayfach, S., Rodriguez-Mueller, B., Garud, N. & Pollard, K. S. An integrated metagenomics pipeline for strain profiling reveals novel patterns of bacterial transmission and biogeography. Genome Res. 26, 1612-1625 (2016).
47. Palm, N. W. et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000-1010 (2014).
48. Pascal, V. et al. A microbial signature for Crohn's disease. Gut 66, 813-822 (2017).
49. Halfvarson, J. et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat. Microbiol. 2, 17004 (2017).
50. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392 (2014).
51. Rogers, A. B. & Houghton, J. in Inflammation and Cancer: Methods in Molecular Biology Vol. 511 (ed. Kozlov, S. V.) 267-295 (Humana, New York, 2009).
52. Cox, D. & Snell, E. J. Analysis of Binary Data (Chapman and Hall/CRC, London, 1989).
53. Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. USA 108, 4516-4522 (2011).
54. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
55. Aronesty, E. Comparison of sequencing utility programs. Open Bioinformatics J. 7, 1-8 (2013).
56. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
57. McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610-618 (2012).
58. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
59. Abubucker, S. et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 8, 1002358 (2012).
60. Bittinger, K. qiimer: Work with QIIME Output Files in R. R package v. 0. 9. 4 (CRAN, 2015); https://CRAN. R-project. org/package=qiimer
61. McDonald, D. et al. The biological observation matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. GigaScience 1, 1-6 (2012)
62. McMurdie, P. J. & Holmes, S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).
63. Dixon, P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 14, 927-930 (2003).